<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166480">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01881698</url>
  </required_header>
  <id_info>
    <org_study_id>1426/2013</org_study_id>
    <nct_id>NCT01881698</nct_id>
  </id_info>
  <brief_title>Evaluation of Platelet Function in Pregnancy With Multiple Electrode Aggregometry</brief_title>
  <acronym>MULPP</acronym>
  <official_title>Multiple Electrode Aggregometry and Platelet Function in Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Establishment of a range of normal values in pregnancy with the Multiple Electrode
      Aggregometry (Multiplate@) device, a device that allows measurement of not only platelet
      count but platelet function. This has not been studied in ths special patient group. Results
      from this trial will be used as a basis for further investigation of abnormal platelet
      function in pregnancy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>7 Months</target_duration>
  <primary_outcome>
    <measure>Change of platelet function</measure>
    <time_frame>4x, as specified below</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement of change of platelet function by the Multiplate® device. First measurement (baseline measurement) at enrollment into the trial. Second measurement during government-mandated gynaecological evaluation, around the 20th week of pregnancy.
Third measurement immediately prior to delivery. Last measurement one week after delivery. 2nd, 3rd and 4th measurement for assessment of change from baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Platelet-associated complications</measure>
    <time_frame>4x, as specified below (baseline, 20th week)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Record of bleeding events, preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
Time points: at every assessment of primary outcome measure, as described above.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Platelet Function</condition>
  <condition>Pregnancy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Platelet function during pregnancy Multiple Electrode Aggregometry (Multiplate@) device</intervention_name>
    <description>Observation of platelet function in pregnancy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant patients above the age of majority
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnancy

        Exclusion Criteria:

          -  Rejection of informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reinhard Hahn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesia, General Intensive Care and Pain Management, Medical University Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reinhard Hahn, MD</last_name>
    <phone>0043 1 40400</phone>
    <phone_ext>4100</phone_ext>
    <email>reinhard.hahn@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Albert M de Bettignies</last_name>
    <phone>0043 1 40400</phone>
    <email>n0826451@students.meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinik für Frauenheilkunde, Allgemeines Krankenhaus der Stadt Wien</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 10, 2013</lastchanged_date>
  <firstreceived_date>May 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Reinhard Hahn</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>platelet function</keyword>
  <keyword>monitoring</keyword>
  <keyword>multiple electrode aggregometry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
